Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 appears to be a minor version change and does not alter study details or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check20 days agoChange DetectedThe funding/operating status notice has been removed from the page; the informational block about potential updates and NIH operations is no longer displayed.SummaryDifference0.4%

- Check34 days agoChange DetectedPage content remains unchanged; only minor formatting and layout tweaks were observed without altering study details such as eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check70 days agoChange DetectedVersion updated from v3.0.2 (Deletions) to v3.1.0 (Additions).SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.